Masimo Acquires Lidco For $40.3M In Cash, Adds Complementary Hemodynamic Monitoring Tech

04 Nov 2020

Masimo’s planned buyout of Lidco could help expand its footprint into the US.

Blood haematology analyzer. Close up of medical worker in lab. - Image

There have been few acquisitions in the hemodynamics monitoring space recently, but Masimo Corp.’s $40.3m cash offer for the UK-based LiDCO Group Plc is a good fit, according to BTIG analyst Marie Thibault.

“Lidco’s technology is complementary to Masimo’s Pleith Variabilty Index and SpHb total hemoglobin monitoring parameters, so should add to clinician...